Cargando…

STATIN USE AT TIME OF RESPIRATORY VIRAL INFECTION IN PATIENTS WITH PRIOR HISTORY OF CARDIOVASCULAR DISEASE AND RISK OF SUBSEQUENT CARDIOVASCULAR EVENTS

Detalles Bibliográficos
Autores principales:	Knight, Stacey, III, Russell R. Miller, Bair, Tami, Horne, Benjamin, Lopansri, Bert K., Anderson, Jeffrey, Muhlestein, J., Carlquist, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Cardiology Foundation. Published by Elsevier Inc. 2015
Materias:	Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135612/ http://dx.doi.org/10.1016/S0735-1097(15)61444-9

Ejemplares similares

A COMPARISON OF CARDIOVASCULAR OUTCOMES AMONG SARS-COV-2 POSITIVE PATIENTS, SARS-COV-2 NEGATIVE PATIENTS, AND A HISTORICAL COHORT
por: May, Heidi Thomas, et al.
Publicado: (2023)

Is Alcohol Consumption Associated with a Lower Risk of Cardiovascular Events in Patients Treated with Statins? An Observational Real-World Experience
por: Anderson, Jeffrey L., et al.
Publicado: (2022)

IMPACT OF THE COVID PANDEMIC ON DEPRESSIVE SYMPTOMS AND SEVERITY
por: May, Heidi Thomas, et al.
Publicado: (2023)

Higher docosahexaenoic acid levels lower the protective impact of eicosapentaenoic acid on long-term major cardiovascular events
por: Le, Viet T., et al.
Publicado: (2023)

Cardiovascular Outcomes of ST-Elevation Myocardial Infarction (STEMI) Patients without Standard Modifiable Risk Factors (SMuRF-Less): The Intermountain Healthcare Experience
por: Anderson, Jeffrey L., et al.
Publicado: (2022)

DOES ABO BLOOD GROUP INFLUENCE RISK OR SEVERITY OF COVID-19?
por: Anderson, Jeffrey L., et al.
Publicado: (2021)

Association of Sociodemographic Factors and Blood Group Type With Risk of COVID-19 in a US Population
por: Anderson, Jeffrey L., et al.
Publicado: (2021)

ROUTINE PERIODIC FASTING IS ASSOCIATED WITH A LOWER RISK OF INPATIENT HOSPITALIZATION FOR THE PRIMARY DIAGNOSIS OF HEART FAILURE FOLLOWING COVID-19 DIAGNOSIS
por: Horne, Benjamin Davies, et al.
Publicado: (2023)

Atrial fibrillation is a risk factor for major adverse cardiovascular events in COVID-19
por: Cutler, Michael J., et al.
Publicado: (2022)

Statin tolerability: In defence of placebo-controlled trials
por: Tobert, Jonathan A, et al.
Publicado: (2015)

Sub-optimal cholesterol response to initiation of statins and future risk of cardiovascular disease
por: Akyea, Ralph Kwame, et al.
Publicado: (2019)

Eligibility for cardiovascular risk screening among different ethnic groups: The HELIUS study
por: Perini, Wilco, et al.
Publicado: (2019)

Frequency and Outcomes of Patients Presenting with Non-ST Elevation Myocardial Infarction (NSTEMI) without Standard Modifiable Risk Factors: A US Healthcare Experience
por: Anderson, Jeffrey L., et al.
Publicado: (2023)

BENEFIT for all: An ecosystem to facilitate sustained healthy living and reduce the burden of cardiovascular disease
por: Keesman, Mike, et al.
Publicado: (2018)

Hemodynamic Gain Index Is Associated With Cardiovascular Mortality and Improves Risk Prediction: A PROSPECTIVE COHORT STUDY
por: Laukkanen, Jari A., et al.
Publicado: (2023)

Health literacy is associated with health behaviour and self-reported health: A large population-based study in individuals with cardiovascular disease
por: Aaby, Anna, et al.
Publicado: (2017)

A cross-sectional survey of cardiovascular health and lifestyle habits of hospital staff in the UK: Do we look after ourselves?
por: Mittal, Tarun K, et al.
Publicado: (2017)

Assessing gaps in cholesterol treatment guidelines for primary prevention of cardiovascular disease based on available randomised clinical trial evidence: The Rotterdam Study
por: Pavlović, Jelena, et al.
Publicado: (2017)

Association of periodic fasting with lower severity of COVID-19 outcomes in the SARS-CoV-2 prevaccine era: an observational cohort from the INSPIRE registry
por: Horne, Benjamin D, et al.
Publicado: (2022)

An analysis of the effect of statins on the risk of Non‐Hodgkin's Lymphoma in the Women’s Health Initiative cohort
por: Desai, Pinkal, et al.
Publicado: (2018)

Vitamin E Supplementation and Cardiovascular Health: A Comprehensive Review
por: Kumar, Mayank, et al.
Publicado: (2023)

A new ratio for better predicting future death/myocardial infarction than standard lipid measurements in women >50 years undergoing coronary angiography: the apolipoprotein A1 remnant ratio (Apo A1/ [VLDL(3)+IDL])
por: May, Heidi T, et al.
Publicado: (2013)

Association of the Intermountain Risk Score with major adverse health events in patients positive for COVID-19: an observational evaluation of a US cohort
por: Horne, Benjamin D, et al.
Publicado: (2022)

The history of proprotein convertase subtilisin kexin-9 inhibitors and their role in the treatment of cardiovascular disease
por: Kim, Eun Ji, et al.
Publicado: (2020)

Elevated cardiovascular disease risk in low-income women with a history of pregnancy loss
por: Tsulukidze, Maka, et al.
Publicado: (2022)

Cervical cancer screening history prior to a diagnosis of cervical cancer in Danish women aged 60 years and older—A national cohort study
por: Hammer, Anne, et al.
Publicado: (2019)

Net benefit of statins for primary prevention of cardiovascular disease in people 75 years or older: a benefit–harm balance modeling study
por: Yebyo, Henock G., et al.
Publicado: (2019)

Lifestyle Intervention for Cardiovascular Disease Risk Factors in Jeddah, Saudi Arabia
por: Khouja, Jumana H, et al.
Publicado: (2020)

Preferential Metabolic Improvement by Intermittent Fasting in People with Elevated Baseline Red Cell Distribution Width: A Secondary Analysis of the WONDERFUL Randomized Controlled Trial
por: Horne, Benjamin D., et al.
Publicado: (2021)

Intermittent fasting and changes in clinical risk scores: Secondary analysis of a randomized controlled trial
por: Horne, Benjamin D., et al.
Publicado: (2023)

Mortality and high risk of major adverse events in patients with COVID-19 and history of cardiovascular disease
por: Tessitore, Elena, et al.
Publicado: (2021)

LIMITED ENGLISH PROFICIENCY, CARDIOVASCULAR RISK FACTORS, CARDIOVASCULAR DISEASE AND IN-HOSPITAL COVID-19 OUTCOME
por: Berkowitz, Julia L., et al.
Publicado: (2023)

Incidence rates of cardiovascular outcomes in a community‐based population of cancer patients
por: Masson, Rajeev, et al.
Publicado: (2019)

Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomide
por: Rollison, Dana E., et al.
Publicado: (2016)

Cardiovascular disease risk factors in relation to smoking behaviour and history: a population-based cohort study
por: Keto, Jaana, et al.
Publicado: (2016)

Aspartate aminotransferase/alanine aminotransferase ratio and subsequent cancer development
por: Kobayashi, Daiki, et al.
Publicado: (2021)

Long‐term risk of cardiovascular mortality in lymphoma survivors: A systematic review and meta‐analysis
por: Boyne, Devon J., et al.
Publicado: (2018)

A Systematic Review of Major Cardiovascular Risk Factors: A Growing Global Health Concern
por: Adhikary, Dipannita, et al.
Publicado: (2022)

Statin uses and mortality in colorectal cancer patients: An updated systematic review and meta‐analysis
por: Li, Yue, et al.
Publicado: (2019)

Statin Use Reduces the Risk of Hepatocellular Carcinoma: An Updated Meta-Analysis and Systematic Review
por: Khazaaleh, Shrouq, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lu7apl3o6he3meedadr52ts934